| VERV Stock | | | USD 5.78 0.23 4.14% |
Verve Therapeutics Price To Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price To Sales Ratio will likely drop to 13.96 in 2025.
Check out the analysis of
Verve Therapeutics Correlation against competitors.
For more information on how to buy Verve Stock please use our
How to Invest in Verve Therapeutics guide.
Latest Verve Therapeutics' Price To Sales Growth Pattern
Below is the plot of the Price To Sales Ratio of Verve Therapeutics over the last few years. Price to Sales Ratio is figured by comparing Verve Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Verve Therapeutics sales, a figure that is much harder to manipulate than other Verve Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Verve Therapeutics' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Verve Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 15.87 X | 10 Years Trend | | |
Verve Price To Sales Regression Statistics
| Arithmetic Mean | 444.13 |
| Geometric Mean | 302.84 |
| Coefficient Of Variation | 45.81 |
| Mean Deviation | 153.46 |
| Median | 538.57 |
| Standard Deviation | 203.45 |
| Sample Variance | 41,391 |
| Range | 525 |
| R-Value | (0.68) |
| Mean Square Error | 23,826 |
| R-Squared | 0.46 |
| Significance | 0 |
| Slope | (29.07) |
| Total Sum of Squares | 620,858 |
Verve Price To Sales History
| 2025 | 13.96 | |
| 2024 | 14.69 | |
| 2023 | 76.08 | |
About Verve Therapeutics Financial Statements
Verve Therapeutics investors use historical fundamental indicators, such as Verve Therapeutics' Price To Sales, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Verve Therapeutics. Please read more on our
technical analysis and
fundamental analysis pages.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Verve Stock Analysis
When running Verve Therapeutics' price analysis, check to
measure Verve Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verve Therapeutics is operating at the current time. Most of Verve Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Verve Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verve Therapeutics' price. Additionally, you may evaluate how the addition of Verve Therapeutics to your portfolios can decrease your overall portfolio volatility.